The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 16, 2023

Filed:

Feb. 20, 2021
Applicant:

Gholam A. Peyman, Sun City, AZ (US);

Inventor:

Gholam A. Peyman, Sun City, AZ (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 31/14 (2006.01); A61K 9/00 (2006.01); A61K 31/706 (2006.01); A61K 31/4045 (2006.01); A61K 31/727 (2006.01); A61K 31/5415 (2006.01); A61K 31/225 (2006.01); A61K 31/343 (2006.01); A61K 31/353 (2006.01); A61K 45/06 (2006.01); A61K 33/30 (2006.01); A61K 9/50 (2006.01); C07K 16/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/727 (2013.01); A61K 9/0053 (2013.01); A61K 9/5031 (2013.01); A61K 9/5036 (2013.01); A61K 31/225 (2013.01); A61K 31/343 (2013.01); A61K 31/353 (2013.01); A61K 31/5415 (2013.01); A61K 33/30 (2013.01); A61K 45/06 (2013.01); C07K 16/08 (2013.01);
Abstract

A method of treating, reducing, or alleviating a medical condition in a patient is disclosed herein. The method includes administering to a patient in need thereof a biocompatible drug comprising one or more antiviral medications together with one or more cell pathway inhibitors, the patient having at least one of a respiratory tract inflammatory disease, a central nervous system inflammatory disease, and vasculitis. The one or more antiviral medications preventing an attachment of viruses to cell walls, blocking a penetration of the viruses into cells, and/or inhibiting virus replication by damaging nucleic acids of the viruses. The one or more cell pathway inhibitors blocking an inflammatory response of inflamed tissue without inhibiting an immune response of the patient.


Find Patent Forward Citations

Loading…